Results 211 to 220 of about 20,261,505 (305)
A multicenter randomized controlled trial of recombinant interferon-α2b in patients with acute transfusion-associated hepatitis C [PDF]
Pietro Lampertico+6 more
openalex +1 more source
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
C. Jopling+4 more
semanticscholar +1 more source
The study successfully developed and validated a granulomatous liver injury model using a high‐dose BCG vaccine, simulating hepatic tuberculosis and autoimmune granulomatous liver diseases. Pharmacokinetic analysis examined the metabolic behavior of first‐line antitubercular drugs (isoniazid and rifampicin) and their main metabolites under conditions ...
Swati Sharma+8 more
wiley +1 more source
Abstract Background Clinical factors favouring coronary angiography (CA) selection and variables associated with in‐hospital mortality among patients presenting with out‐of‐hospital cardiac arrest (OHCA) without ST‐segment elevation (STE) remain unclear.
Wayne C. Zheng+15 more
wiley +1 more source
Detection of Chronic Hepatitis C Virus Infection by Four Diagnostic Systems: First–Generation and Second–Generation Enzyme–Linked Immunosorbent Assay, Second–Generation Recombinant Immunoblot Assay and Nested Polymerase Chain Reaction Analysis [PDF]
Yoshiyuki Nakatsuji+4 more
openalex +1 more source
Application of humanized mice in the safety experiments of antibody drugs
The graphical abstract of this review highlights the critical role of humanized mice in the safety evaluation of antibody drugs. First, the inherent immunogenicity of antibody drugs can lead to the production of antidrug antibodies and hypersensitivity reactions on repeated administration.
Zhimin Sun+9 more
wiley +1 more source
Molecular model of the specificity pocket of the hepatitis C virus protease: implications for substrate recognition. [PDF]
Elisabetta Pizzi+7 more
openalex +1 more source
Profound Thrombocytopenia and Dyspnea 11 Days After Cardiac Surgery
American Journal of Hematology, EarlyView.
Sebastian Vuong+3 more
wiley +1 more source
Fuke Huahuang formulation (FHF) is used to treat vaginitis, and it exerts a promising anti‐inflammatory effect in clinical use. However, the detailed components and mechanisms of FHF for treating vaginitis remain unreported, and further preclinical evaluation is required to reveal its potential pharmacological activities against vaginitis.
Huiyu Liu+5 more
wiley +1 more source